Skip Navigation
Department of Health and Human Services www.hhs.gov
 
Slide Tray
0 slides

Return to Slide Library

Slides

Add Presentation to Slide Tray Presentation:

Disease-Modifying Antirheumatic Drugs in Children With Juvenile Idiopathic Arthritis

Slide: 8 of 46

DMARDs for Treating JIA (2 of 2)

Methotrexate, a nonbiologic DMARD, is widely used and is considered by many to be part of standard care.

Although studies in pediatric populations have been performed, the evidence base regarding DMARDs for treatment of JIA is more limited compared with the wider experience and clinical evidence base in adult rheumatoid arthritis.

Long-term safety of the DMARDs  used in children with JIA is not well understood.